Antibody Discovery and Development Efforts Fueling the Future of Diagnostic Testing

Rapid antibody discovery with synthetic human antibody libraries and HT-SPR™

Date & Time

August 19, 2020 | 8 am PDT (5 pm CEST)

Webinar Description

Join our upcoming webinar to learn how Twist Biopharma has used its proprietary platform to produce and discover highly specific antibodies which may be used for developing diagnostic tests.

In this jointly hosted webinar, you will:

  • Hear how Twist Biopharma, a division of Twist Bioscience, has developed a proprietary platform that uses Twist’s high-throughput DNA synthesis to produce and discover highly specific antibodies.
  • Learn how this platform has been used to discover over 100 high-affinity antibodies to the SARS-CoV-2 spike protein. 
  • See how Twist is using the Carterra LSA high throughput surface plasmon resonance (SPR) platform to bypass ELISA screening and proceed directly to binding kinetics and epitope binning after panning, thereby consolidating mAb workflows and reducing time to results.
  • Learn how to survey the epitope landscape of your antibody library at the earliest stages of discovery.
Webinar Registration

Noah Ditto, MS, MBA

Technical Product Manager
Carterra
Noah T. Ditto, MS, MBA is the Technical Product Manager at Carterra. Prior to joining Carterra in 2014, Noah supported Drug Discovery and Early Clinical Development for nearly a decade at Bristol-Myers Squibb in Princeton, NJ with a focus on biophysical characterization of protein and peptide-based biomarkers, drug targets, and therapeutics. Noah earned his MS from The Pennsylvania State University developing chromatography-based fractionation techniques to isolate relevant serum biomarkers in Dengue infection and his MBA at West Chester University concentrating on Business Analytics.

Aaron Sato, PhD

Chief Scientific Officer
Twist Biopharma
Aaron is the CSO of the Biopharma Vertical at Twist Bioscience. Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center, which discovers novel antibody therapeutics for its clients. He also oversaw all discovery research functions both as Vice President of Protein Sciences at Surrozen, and previously, as Vice President of Research at Sutro Biopharma, Inc. He also held director level positions at both Oncomed and Dyax Corp.
©. All Rights Reserved Twist Bioscience.